Neurokinin 1 Receptor Antagonists for Pruritus Majid AlamJoerg BuddenkotteMartin Steinhoff Leading Article Open access 06 March 2021 Pages: 621 - 634
Fabry Disease: The Current Treatment Landscape Malte LendersEva Brand Review Article Open access 15 March 2021 Pages: 635 - 645
Pathophysiology and Management of Variceal Bleeding Saleh A. AlqahtaniSunguk Jang Review Article 12 March 2021 Pages: 647 - 667
Novel Treatments for Mantle Cell Lymphoma: From Targeted Therapies to CAR T Cells Danielle WallacePatrick M. Reagan Review Article 30 March 2021 Pages: 669 - 684
Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry José David Torres-PeñaLuis M. Pérez-Belmontefor the SEMI-COVID-19 Network Original Research Article 29 March 2021 Pages: 685 - 695
Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC James E. Frampton Adis Drug Evaluation Open access 19 April 2021 Pages: 697 - 708
Indacaterol/Glycopyrronium/Mometasone: A Review in Asthma Hannah A. Blair Adis Drug Evaluation 19 April 2021 Pages: 709 - 719
Vericiguat: First Approval Anthony MarkhamSean Duggan AdisInsight Report 26 March 2021 Pages: 721 - 726
Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases Yvette N. Lamb Correction 13 April 2021 Pages: 733 - 733
Correction to: Secukinumab: A Review in Psoriatic Arthritis Hannah A. Blair Correction Open access 15 April 2021 Pages: 735 - 735
Correction to: Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome Yahiya Y. Syed Correction Open access 19 April 2021 Pages: 737 - 737